- Home
- TCMD vs TERN Comparison
TCMD vs TERN Comparison
Compare TCMD & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- TERN
- Stock Information
- Founded
- TCMD 1995
- TERN 2017
- Country
- TCMD United States
- TERN United States
- Employees
- TCMD N/A
- TERN N/A
- Industry
- TCMD Medical/Dental Instruments
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- TCMD Health Care
- TERN Health Care
- Exchange
- TCMD Nasdaq
- TERN Nasdaq
- Market Cap
- TCMD 362.7M
- TERN 355.9M
- IPO Year
- TCMD 2016
- TERN 2021
- Fundamental
- Price
- TCMD $15.05
- TERN $4.01
- Analyst Decision
- TCMD Hold
- TERN Buy
- Analyst Count
- TCMD 2
- TERN 5
- Target Price
- TCMD $18.00
- TERN $18.30
- AVG Volume (30 Days)
- TCMD 353.1K
- TERN 1.7M
- Earning Date
- TCMD 02-18-2025
- TERN 03-13-2025
- Dividend Yield
- TCMD N/A
- TERN N/A
- EPS Growth
- TCMD N/A
- TERN N/A
- EPS
- TCMD 0.70
- TERN N/A
- Revenue
- TCMD $292,984,000.00
- TERN N/A
- Revenue This Year
- TCMD $8.83
- TERN N/A
- Revenue Next Year
- TCMD $9.86
- TERN N/A
- P/E Ratio
- TCMD $21.41
- TERN N/A
- Revenue Growth
- TCMD 6.76
- TERN N/A
- 52 Week Low
- TCMD $11.12
- TERN $3.96
- 52 Week High
- TCMD $21.10
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- TCMD 29.47
- TERN 33.73
- Support Level
- TCMD $14.60
- TERN $4.01
- Resistance Level
- TCMD $18.06
- TERN $4.24
- Average True Range (ATR)
- TCMD 0.64
- TERN 0.21
- MACD
- TCMD -0.24
- TERN 0.01
- Stochastic Oscillator
- TCMD 13.01
- TERN 5.59
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.